AstraZeneca will discontinue the Zoladex 3.6mg implant in Australia from November 2026, affecting people with breast cancer ...

Patients have been left frustrated and scared after learning that a life-saving breast cancer and endometriosis drug is to be ...

The Pharmaceutical Benefits Scheme has announced plans to de-list a popular medication used to treat debilitating women’s health issues, leaving many Aussies to cover the costs of their necessary ...

This drug is used to treat endometriosis and some breast cancers, but will soon be stripped from Australian shelves.

UCHealth is slicing the cost of a cancer drug after acknowledging it had been overcharging patients and insurance companies for years. The move, following a Coloradoan investigation into the health ...

AstraZeneca lost a federal appeals court ruling and must pay $13 million in damages for manipulating the price of prostate cancer drug Zoladex. The case involved an AZ campaign to persuade doctors to ...

TerSera has obtained Health Canada's approval for a supplemental new drug submission for ZOLADEX LA (goserelin acetate) 10.8mg administered every 12 weeks to manage oestrogen receptor-positive (ER+) ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. ZOLADEX 10.8 mg contains the active ingredient goserelin acetate.

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. ZOLADEX 3.6 mg contains the active ingredient goserelin acetate.

Follow the latest headlines from ABC News, Australia's most trusted media source, with live events, audio and on-demand video ...